v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Aug. 02, 2025
Jul. 27, 2024
Operating activities    
Net (loss) income $ (67,370,000) $ 21,166,000
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:    
Depreciation and amortization 90,254,000 8,852,000
(Gain) from equity method investments (1,787,000) (65,000)
Amortization of debt issuance costs 7,829,000 266,000
Provision for credit losses 173,000 (101,000)
Reserve for inventory excess and obsolescence 1,178,000 2,667,000
Other non-cash expense, net 616,000 616,000
Non-cash lease expense 6,850,000 2,430,000
Loss on foreign currency transactions 161,000 142,000
Unrealized (gain) loss on available-for-sale equity securities, net (2,702,000) 321,000
Deferred income taxes   (1,000)
Stock-based compensation 11,429,000 4,536,000
Loss on disposal of property and equipment 48,000 143,000
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (15,693,000) 34,993,000
Unbilled receivables and retentions (74,510,000) (20,274,000)
Inventories (12,704,000) 3,867,000
Income taxes receivable (16,390,000) (336,000)
Prepaid expenses and other assets (1,749,000) (814,000)
Accounts payable (29,625,000) (4,976,000)
Other liabilities (19,734,000) (25,081,000)
Net cash (used in) provided by operating activities (123,726,000) 28,351,000
Investing activities    
Acquisition of property and equipment (22,728,000) (5,430,000)
Contributions in equity method investments   (1,183,000)
Acquisition of capitalized software to be sold (9,340,000)  
Business acquisitions, net of cash acquired (844,580,000)  
Net cash used in investing activities (876,648,000) (6,613,000)
Financing activities    
Proceeds from shares issued, net of underwriter costs 968,515,000  
Proceeds from convertible debt, net of underwriter costs 726,944,000  
Payment of debt issuance costs (2,445,000)  
Payment of equity issuance costs (1,388,000)  
Tax withholding payment related to net settlement of equity awards (10,786,000) (3,953,000)
Employee stock purchase plan contributions 2,467,000  
Exercise of stock options   506,000
Other (5,000) (7,000)
Net cash provided by (used in) financing activities 1,645,443,000 (13,954,000)
Effects of currency translation on cash and cash equivalents (128,000) 77,000
Net increase in cash and cash equivalents 644,941,000 7,861,000
Cash and cash equivalents at beginning of period 40,862,000 73,301,000
Cash and cash equivalents at end of period 685,803,000 81,162,000
Cash paid, net during the period for:    
Income taxes (223,000) (101,000)
Interest 11,854,000 370,000
Non-cash activities    
Issuance of common stock for business acquisition 2,640,365,000  
Change in foreign currency translation adjustments 639,000 538,000
Acquisitions of property and equipment included in accounts payable 1,951,000 1,208,000
Term loan    
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:    
Amortization of debt issuance costs 6,668,000  
Financing activities    
Principal payments of term loan (700,000,000) $ (10,500,000)
Proceeds from term loan 693,202,000  
Revolving credit facility    
Financing activities    
Principal payments of revolver (265,000,000)  
Proceeds from revolver, net of creditor costs $ 233,939,000